期刊文献+

甲状腺乳头状癌病理组织学亚型及其临床意义 被引量:2

Histopathological Subtypes of Papillary Carcinoma of the Thyroid
下载PDF
导出
摘要 本文结合1954年(?)1978年间外科治疗甲状腺乳头状癌268例病理资料,参照癌组织结构和癌细胞的分化程度,将本瘤分成Ⅰ型(分化较好型)、Ⅱ型(中间型)及Ⅲ型(分化较差型)3个亚型、临床观察,3型的临床表现各异,经外科治疗后,10年以上无瘤生存率分别为93.6%、66.6%及20%(P<0.01)基本符合Ⅰ、Ⅱ、Ⅲ型分别从较好到较差的逐级改变.对临床处理及判断预后有参考意义. Two hundred and sixty eight cases of papillary thyroid carcinoma treated with surgery during 1954-1976 were divided into three histological subtypes s fairly well differentiated type(140 cases,52. 2%),intermediate type (106 cases,39. 6%) ,and rather poor differentiated type(22 cases,8. 2%)based on various features of histologic structure and degree of differentiation of the tumor cells. Clinical observation revealed that clinical pictures of these types were distinctly different from type to type. The 10-year survival rates of patients in order of the above three subtypes were 93. 6 % ,66. 6% and 20% (P<0. 01) respectively.As a result ,it would be justified to regard the three types of lesions as histopathological entities of the papillary carcinoma of the thyroid.
作者 刘科 曾镕
机构地区 天津市肿瘤医院
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1994年第1期37-39,T000,共4页 Chinese Journal of Clinical Oncology
关键词 病理组织学 乳头状癌 甲状腺肿瘤 Papillary carcinoma Thyroid Histology
  • 相关文献

同被引文献14

  • 1叶超平,陈骥,吴瑞兰,陈渊源,(?)怀阳.甲状腺癌颈淋巴结转移相关因素分析[J].实用外科杂志,1993,13(6):349-351. 被引量:5
  • 2WHO肿瘤新分类[J].诊断病理学杂志,1994,1(2):126-127. 被引量:1
  • 3杨其昌,韩枋.171例甲状腺癌的临床病理与预后分析[J].临床与实验病理学杂志,1995,11(1):47-49. 被引量:14
  • 4Usuki K, Heldin NE, Miyazono K, et al. Production of plateletderived endothelial cell growth factor by normal and transformed human cells in culture [ J ]. Proc Natl Acad Sci, 1989, 86 ( 19 ) :7427-7431.
  • 5Dhar DK, Kubota H; Kotoh T, et al. Tumor vascularity predicts recurrence in differentiated thyroid carcinoma [ J ]. Am J Surg,1998,176(5) : 442-447.
  • 6Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-betal is significandy correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma [ J ]. Cancer, 1999,86 (8) : 1455-1462.
  • 7Ohta Y, Watanabe Y, Murakami S, et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer [J]. Br J Cancer, 1997, 76(8):1041-1045.
  • 8Klein M, Picard E, Vignaud JM,et al. Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma[J]. J Endocrinol, 1999,161(1) :41-49.
  • 9Dhar DK, Kubota H, Kotoh T, et al. Tumor vascularity predicts recurrence in differentiated thyroid carcinoma [J]. Am J Surg,1998,176(5) : 442-447.
  • 10Akslen LA, Livolsi VA. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance [ J ]. Hum Pathol,2000.31 (4) :439-442.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部